The Annexure

News to 9 October 2026 ·

Desk›Healthcare› ANG Lifesciences India Ltd

ANG Lifesciences India Ltd

BSE 540694 · NSE ANG · ISIN INE236W01016 · Group T · Active

Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals

₹30.77

+4.98%

BSE close, 28 August 2026

Market cap

₹40.18 cr

1.3 cr shares · Micro cap

Free float

₹11.81 cr

as published

P/E · P/B

— · —

EPS — · BV —

FY25-26 rev / PAT

91.61 / -4.73

₹ cr, as filed

Filings, window

13

3 selected · 23%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹17.63 52-WK HIGH ₹49.69 ₹30.77 41% of range
Against 52-week high-38.1%
Against 52-week low+74.5%
Day change+4.98%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share—
Price / earnings—
Price / book—
Book value — derived, price ÷ P/B—
Return on equity-10.03%
Operating margin-9.11%
Net margin-24.49%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 13.96 -3.42 -2.59 -9.11% -24.49%
Mar-26 · Q 22.80 1.10 0.90 21.09% 4.84%
FY25-26 91.61 -4.73 -3.52 8.01% -5.16%

Quarter on quarter

Revenue, quarter on quarter
-38.8%
Net profit, quarter on quarter
-410.9%
Operating margin, quarter on quarter
-3,020 bps

Disclosure profile 13 filings in the window

0 median 17.0 p75 · 25 sector max 52 13 34th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Change in Management1
Results1
Selected sub-total3
Procedural
AGM / EGM4
Annual Report1
Board Meeting1
Book Closure1
Compliance Certificate1
Outcome1
Trading Window1
Procedural sub-total10
Total13

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group T, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

13 filings · 3 selected · busiest 2026-09-07

Filing rhythm · the twelve most recent

2026-08-072026-10-01

SelectedProcedural

Filings

13 in the window · 2 earlier on record

  1. 1 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Scrutinizer's Report for AGM along with Voting Results

    AGM/EGM / AGM View filing →

  2. 30 September 2026 ·

    Change in Management

    Change in Management

    Re-appointment of Ms. Chetna as the Independent Director of the company.

    Company Update / Change in Management View filing →

  3. 30 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Proceedings of 20th Annual General Meeting are enclosed herewith.

    AGM/EGM / AGM View filing →

  4. 23 September 2026 ·

    Trading Window

    Closure of Trading Window

    Intimation of Closure of Trading Window.

    Insider Trading / SAST / Closure of Trading Window View filing →

  5. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Pursuant to Regulations 30 and 34 of the SEBI (LODR) Regulations, 2015, as amended (' Listing Regulations'), please find attached herewith the Annual Report of the Company for the ....

    Others / Reg. 34 (1) Annual Report View filing →

  6. 7 September 2026 ·

    AGM / EGM

    Notice Of 20Th AGM Of The Company On Wednesday, 30Th September, 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM).

    Notice of 20th AGM

    AGM/EGM / AGM View filing →

  7. 7 September 2026 ·

    Book Closure

    Intimation Of Book Closure

    Intimation of Book Closure

    Corp. Action / Book Closure View filing →

  8. 7 September 2026 ·

    AGM / EGM

    Intimation Of 20Th Annual General Meeting

    Intimation of 20th Annual General Meeting

    AGM/EGM / AGM View filing →

  9. 7 September 2026 ·

    Outcome

    Board Meeting Outcome for Board Meeting Outcome For Board Meeting Outcome For Intimation Of AGM

    This is to inform you, pursuant to Regulation 30 and other applicable regulations of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the Board of Directors ....

    Others / Outcome without intimation View filing →

  10. 14 August 2026 ·

    Results

    Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015

    Financial Results 30.06.2026.

    Result / Financial Results View filing →

  11. 14 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations, 2015

    Submission of standalone and consolidated unaudited financial results for the quarter ended on 30.06.2026 under Regulation 33 of the SEBI (LODR) Regulations, 2015

    Board Meeting / Outcome of Board Meeting View filing →

  12. 7 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026.

    ANG Lifesciences India Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....

    Board Meeting / Board Meeting View filing →

  13. 21 July 2026 ·

    Compliance Certificate

    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    Reg 74(5) Certificate

    Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →

RSS feed for ANG Lifesciences India Ltd · the 50 most recent filings